Professor | Min Luo | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Min Luo
Contact Information	luo_min@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Min Luo

Contact Information

luo_min@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Biomedical Sciences
Academic Background & Achievements	2000.9 – 2005.7 PhD: Peking University, School of Life Sciences 1996.9 – 2000.7 Bachelor's: Peking University, School of Life Sciences
Work Experience	2018.01 - Present - Fudan University, Institute of Biomedical Sciences, Affiliated Pediatric Hospital - Young Researcher, Adjunct Professor 2013.3 - 2018.1 - UT Southwestern Medical Center - Assistant Researcher 2010.9 - 2013.03 - Shenzhen Center for Disease Control and Prevention - Associate Researcher 2007.10 - 2010.8 - Peking University - Lecturer 2005.10 - 2007.9 - Peking University - Postdoctoral Researcher

University/Lab Affiliation and Title

Fudan University

Faculty

Biomedical Sciences

Academic Background & Achievements

2000.9 – 2005.7 PhD: Peking University, School of Life Sciences
1996.9 – 2000.7 Bachelor's: Peking University, School of Life Sciences

Work Experience

2018.01 - Present - Fudan University, Institute of Biomedical Sciences, Affiliated Pediatric Hospital - Young Researcher, Adjunct Professor
2013.3 - 2018.1 - UT Southwestern Medical Center - Assistant Researcher
2010.9 - 2013.03 - Shenzhen Center for Disease Control and Prevention - Associate Researcher
2007.10 - 2010.8 - Peking University - Lecturer
2005.10 - 2007.9 - Peking University - Postdoctoral Researcher

Areas of Focus	Cancer Immunotherapy Tumor Antigen Enriched Cancer Nanovaccines Molecular Mechanisms of T Cells and Tumor Immune Microenvironment Screening of New Tumor Immunotherapy Drugs
Publications	CD300ld on neutrophils is required for tumour-driven immune suppression, Wang C, Zheng X, Zhang J, Jiang X, Wang J, Li Y, Li X, Shen G, Peng J, Zheng P, Gu Y, Chen J, Lin M, Deng C, Gao H, Lu Z, Zhao Y, Luo M, 2023 Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease, Ding H, Li Y, Fang M, Chen J, Liu L, Lu Z, Hou J, Luo M, 2023 Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy, Jiang X, Wang J, Zheng X, Liu Z, Zhang X, Li Y, Wilhelm J, Sumer BD, Lea L, Lu Z, Gao J, Luo M, 2022 Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2, Gu Y, Cao J, Zhang X, Gao H, Wang Y, Wang J, Jiang X, Zhang J, Shen G, Yang J, Zheng X, Xu J, Lan F, Qu D, Zhao Y, Xu G, Xie Y, Luo M, Lu Z, 2022 Efficient expansion of mouse hematopoietic stem cells ex vivo by membrane anchored Angptl2, Yang J, Shen G, Cao J, Zhang J, Gu Y, Zhang X, Jiang X, Luo M, Lu Z, 2022 Prolonged activation of innate immune pathways by a polyvalent STING agonist, Li S, Luo M, Wang Z, Fu YX, Baran S, Yu H, Gao J, 2021 Nanoengineered targeting strategy for cancer immunotherapy, Yin WM, Li YW, Gu YQ, Luo M, 2020 ONM-500 – a novel STING-activating therapeutic nanovaccine platform for cancer immunotherapy, Miller J, Luo M, ChenZJ, Gao J, Zhao T, 2020 Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy, Luo M, Liu ZD, Fu Yang-Xin, Gao Jinming, 2019 A STING-activating nanovaccine for cancer immunotherapy, Luo M, Wang H, Wang Z, Cai H, Lu Z, Huang G, Chen X, Porembka M, Frankel A, Zhijian J. Chen, Gao J, 2017 Synthetic nanovaccines for T cell immunotherapy, Luo M, Layla Z. Samandi, Zhaohui Wang, Zhijian J. Chen and Jinming Gao, 2017 A Redox Activatable Fluorescent Sensor for the High-Throughput Quantification of Cytosolic Delivery of Macromolecules, Wang Z, Luo M, Mao C, Wei Q, Zhao T, Li Y, Huang G, and Gao J, 2017 Fasting selectively blocks acute lymphoblastic leukemia development via leptin receptor upregulation, Lu Z, Xie J, Wu G, Shen J, Collins R, Chen W, Kang X, Luo M, Zou Y, Huang LJ, Amatruda JF, Slone T, Winick N, Scherer PE, Zhang CC, 2017 A transistor-like pH nanoprobe for tumor detection and image-guided surgery, Zhao T, Huang G, Li Y, Yang S, Ramezani S, Lin Z, Wang Y, Ma X, Zeng Z, Luo M, Boer E, Xie X, Thibodeaux J, Brekken RA, Sun X, Sumer BD, Gao J, 2016

Areas of Focus

Cancer Immunotherapy
Tumor Antigen Enriched Cancer Nanovaccines
Molecular Mechanisms of T Cells and Tumor Immune Microenvironment
Screening of New Tumor Immunotherapy Drugs

Publications

CD300ld on neutrophils is required for tumour-driven immune suppression, Wang C, Zheng X, Zhang J, Jiang X, Wang J, Li Y, Li X, Shen G, Peng J, Zheng P, Gu Y, Chen J, Lin M, Deng C, Gao H, Lu Z, Zhao Y, Luo M, 2023
Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease, Ding H, Li Y, Fang M, Chen J, Liu L, Lu Z, Hou J, Luo M, 2023
Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy, Jiang X, Wang J, Zheng X, Liu Z, Zhang X, Li Y, Wilhelm J, Sumer BD, Lea L, Lu Z, Gao J, Luo M, 2022
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2, Gu Y, Cao J, Zhang X, Gao H, Wang Y, Wang J, Jiang X, Zhang J, Shen G, Yang J, Zheng X, Xu J, Lan F, Qu D, Zhao Y, Xu G, Xie Y, Luo M, Lu Z, 2022
Efficient expansion of mouse hematopoietic stem cells ex vivo by membrane anchored Angptl2, Yang J, Shen G, Cao J, Zhang J, Gu Y, Zhang X, Jiang X, Luo M, Lu Z, 2022
Prolonged activation of innate immune pathways by a polyvalent STING agonist, Li S, Luo M, Wang Z, Fu YX, Baran S, Yu H, Gao J, 2021
Nanoengineered targeting strategy for cancer immunotherapy, Yin WM, Li YW, Gu YQ, Luo M, 2020
ONM-500 – a novel STING-activating therapeutic nanovaccine platform for cancer immunotherapy, Miller J, Luo M, ChenZJ, Gao J, Zhao T, 2020
Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy, Luo M, Liu ZD, Fu Yang-Xin, Gao Jinming, 2019
A STING-activating nanovaccine for cancer immunotherapy, Luo M, Wang H, Wang Z, Cai H, Lu Z, Huang G, Chen X, Porembka M, Frankel A, Zhijian J. Chen, Gao J, 2017
Synthetic nanovaccines for T cell immunotherapy, Luo M, Layla Z. Samandi, Zhaohui Wang, Zhijian J. Chen and Jinming Gao, 2017
A Redox Activatable Fluorescent Sensor for the High-Throughput Quantification of Cytosolic Delivery of Macromolecules, Wang Z, Luo M, Mao C, Wei Q, Zhao T, Li Y, Huang G, and Gao J, 2017
Fasting selectively blocks acute lymphoblastic leukemia development via leptin receptor upregulation, Lu Z, Xie J, Wu G, Shen J, Collins R, Chen W, Kang X, Luo M, Zou Y, Huang LJ, Amatruda JF, Slone T, Winick N, Scherer PE, Zhang CC, 2017
A transistor-like pH nanoprobe for tumor detection and image-guided surgery, Zhao T, Huang G, Li Y, Yang S, Ramezani S, Lin Z, Wang Y, Ma X, Zeng Z, Luo M, Boer E, Xie X, Thibodeaux J, Brekken RA, Sun X, Sumer BD, Gao J, 2016

Cancer Immunotherapy Nanovaccine Tumor T Cells Immune Microenvironment Molecular Mechanisms Drug Screening Antibodies Vaccines

Xianghuo He - Fudan University

Shenglin Huang - Fudan University

Qiang Gao - Fudan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us